Patents by Inventor David E. Spaner

David E. Spaner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccines Using High-Dose Cytokines
    Publication number: 20160151473
    Abstract: The present invention relates to the field of cancer immunotherapy. In particular, vaccines are administered in conjunction with high doses of cytokines to enhance an anti-tumor immune response.
    Type: Application
    Filed: January 29, 2016
    Publication date: June 2, 2016
    Inventors: David E. Spaner, Neil Berinstein, Mark DeBenedette, Igor Astasturov, Teresa Petrella, Umit Bagriacik, Gail Lumber, Neill Iscoe, Caitlin Hammond, Paul Hamilton
  • Treatment for CD5 B cell lymphoma
    Patent number: 7923429
    Abstract: The present invention provides methods for increasing expression of cell surface molecules of CD5+ B cell lymphoma cells by contacting cells with immune response modifiers. The invention also provides methods for the treatment of CD5+ B cell lymphomas, including chronic lymphocytic leukemia and small lymphocytic lymphoma, by administering immune response modifier compounds to a subject in need of such treatment. Suitable immune response modifier compounds include agonists of TLR7 and/or TLR8.
    Type: Grant
    Filed: July 15, 2008
    Date of Patent: April 12, 2011
    Assignee: 3M Innovative Properties Company
    Inventors: Richard L. Miller, David E. Spaner
  • TREATMENT FOR CD5+ B CELL LYMPHOMA
    Publication number: 20090017076
    Abstract: The present invention provides methods for increasing expression of cell surface molecules of CD5+ B cell lymphoma cells by contacting cells with immune response modifiers. The invention also provides methods for the treatment of CD5+ B cell lymphomas, including chronic lymphocytic leukemia and small lymphocytic lymphoma, by administering immune response modifier compounds to a subject in need of such treatment. Suitable immune response modifier compounds include agonists of TLR7 and/or TLR8.
    Type: Application
    Filed: July 15, 2008
    Publication date: January 15, 2009
    Applicant: Coley Pharmaceutical Group, Inc.
    Inventors: Richard L. Miller, David E. Spaner
  • Vaccines using high-dose cytokines
    Publication number: 20040223949
    Abstract: The present invention relates to the field of cancer immunotherapy. In particular, vaccines are administered in conjunction with high doses of cytokines to enhance an anti-tumor immune response.
    Type: Application
    Filed: October 21, 2003
    Publication date: November 11, 2004
    Applicant: Sunnybrook and Women's College Health Sciences Center Aventis Pasteur, Ltd.
    Inventors: Igor Astsaturov, Teresa Petrella, Mark DeBenedette, Neil Berinstein, David E. Spaner